Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions hosted by UBS, Jefferies, DNB Carnegie, and SEB. Alvotech aims to showcase its progress and engage with investors as it develops and markets biosimilar drugs globally. Recordings of the sessions will be available for 90 days post-event on their website.
Alvotech's participation in November investor conferences provides context for health sector activity on Pluang. Of 150 priced health-sector US stocks, 70 rose and 54 fell today. Notable movers include TWST at USD 157.77 (+3.27%), MMED at USD 17.74 (-2.95%), and ASND at USD 258.31 (+2.90%), as of Nov 02, 2026 18:12 WIB.
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...
Heineken N.V. has repurchased a total of 9,510,681 shares under the second tranche of its €1.5 billion share buyback program, spending €679.2 million as of October 30, 2026. The company bought 159,700 shares on the exchange and 160,530 shares from He...
Alvotech, a global biotech company specializing in biosimilars, announced its management team will participate in several investor conferences in November 2026, including events in London, Oslo, and Stockholm. These presentations and fireside chats w...
Alvotech, a global biotech company specializing in biosimilar medicines, announced its management team will participate in several investor conferences throughout November 2026. These include events in London, Oslo, and Stockholm, featuring presentat...
New research by The Allstate Foundation of Canada shows that while 75% of Canadians have experienced or know someone who has experienced domestic abuse, only 9% recognize financial abuse as a form of it. However, 56% of abuse survivors identified fin...
